Meng Lv

16PUBLICATIONS
42CO-AUTHORS
Haematological tumoursHaematologyMedical infection agents (incl. prions)Transplantation immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 01, 2026
Dual epitope anti-LILRB4 synthetic T-cell receptor and antigen receptor (STAR)-T-cell therapy for relapsed/refractory acute myeloid leukemia.

|Apr 04, 2026
Salvage nintedanib plus low-dose ruxolitinib therapy for bronchiolitis obliterans syndrome refractory to calcineurin inhibitors and glucocorticoids after allogeneic transplantation.

Ya Luo, Ying Wu, Qiu-Sha Huang

|Mar 19, 2026
Donor age ≥50 years combined with donor-CI ≥3 identifies a high-risk cohort for adverse outcomes after allogeneic hematopoietic stem cell transplantation in B-cell acute lymphoblastic leukemia.

Ning Wu, Jun Kong, Meng Lv

|Nov 18, 2025
Outcomes and risk factors of second allogeneic haematopoietic stem cell transplantation in patients with relapsed haematological malignancy after first transplantation.

Xiaolu Zhu, Haixia Fu, Jing Liu

|Sep 03, 2025
The clinical features, risk factors and outcomes of polyomavirus encephalitis after allogeneic haematological stem cell transplantation.

Xu-Ying Pei, Xian-Ying Yin, Hai-Lu Sun

|Jul 28, 2025
Successful Treatment of Lomentospora Prolificans Infection Following Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review.

Yi-Han Yang, Chun Di, Hao Zheng

Pageof 3

Frequent Collaborators

8 joint publications

Xiaojun Huang

6 joint publications

Yu Wang

6 joint publications

Xiaodong Mo

4 joint publications

Xiao-Hui Zhang